Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: Several surrogates for prostate cancer–specific mortality satisfying the Prentice criteria exist, but whether these are surrogates for all-cause mortality, and how their performance compares, is unknown. OBJECTIVE: To ascertain and compare the performance of 4 candidate surrogates (prost...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Oncol
Main Authors: Royce, Trevor J., Chen, Ming-Hui, Wu, Jing, Loffredo, Marian, Renshaw, Andrew A., Kantoff, Philip W., D’Amico, Anthony V.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2017
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5470391/
https://ncbi.nlm.nih.gov/pubmed/28097317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.5983
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares